查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球生物晶片市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023年至2030年預測
市場調查報告書
商品編碼
1307000

全球生物晶片市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023年至2030年預測

Global Biochips Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 121 Pages | 商品交期: 最快1-2個工作天內

價格

預計到2030年，全球生物晶片市場需求將從2022年的89.1億美元成長至271.9億美元，2023-2030年復合年成長率為14.97%。

生物晶片，也稱為微陣列，是由微小晶片或玻璃載玻片組成的小型設備，用於研究DNA、RNA和蛋白質等生物分子。這些裝置有數千至數百萬個微觀點，每個點含有不同的生物分子。它們的工作原理是將感興趣的生物分子與晶片表面的光點結合，然後使用螢光、化學發光或質譜等各種方法對其進行分析。通過分析晶片上每個點的訊號，研究人員可以獲得被分析生物樣品的大量資訊。

市場動態：

個性化醫療是指根據個人的基因構成量身定做醫療方案，這一日益成長的趨勢推動了對生物晶片的需求。生物晶片用於分析DNA、RNA和蛋白質樣本，可為製定個性化治療方案提供有價值的資訊。基因組學和蛋白質組學研究的進展，如下一代測序和質譜技術的發展，也增加了該市場的需求曲線。這些技術用於快速有效地分析大量生物數據。微陣列技術在研究、診斷和藥物開發領域的應用正在迅速增加。生物晶片是微陣列技術的關鍵組成部分，用於研究基因表達和蛋白質相互作用。包括癌症、心血管疾病和糖尿病在內的慢性疾病發病率的上升也支持了這一市場。生物晶片用於診斷、治療和監測這些疾病，由於人口老齡化和不健康的生活方式等因素，這些疾病正變得越來越普遍。晶片實驗室和微流控技術的發展等技術進步也有助於該市場的成長。這些技術能夠更快、更準確地分析生物樣本，對研究和診斷至關重要。各國政府的大量投資也支持了這一市場。例如，美國政府發起了多項旨在推動基因組學研究和個性化醫療的計劃，預計這將促進市場需求。

研究報告包括波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於在全球範圍內清晰地了解行業結構並評估競爭吸引力。此外，這些工具還對全球生物晶片市場的各個細分市場進行了全面評估。生物晶片行業的成長和趨勢為本研究提供了整體方法。

市場細分：

生物晶片市場報告的這一部分提供了國家和地區層面細分市場的詳細數據，從而幫助戰略家確定各自產品或服務的目標人群以及即將到來的機會。

按類型

  • DNA晶片（癌症診斷和治療、基因表達、SNP基因分型、基因組學、藥物發現、農業生物技術、其他）
  • 蛋白質晶片（蛋白質組學、表達譜分析、診斷、HTS、藥物發現、其他）
  • 晶片實驗室（基因組學、IVD和POC、蛋白質組學、藥物研發、其他）
  • 組織晶片
  • 細胞晶片

按最終用戶分類

  • 生物技術和製藥公司
  • 醫院和診斷中心
  • 學術研究機構
  • 其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太、拉丁美洲、中東和非洲地區生物晶片市場的當前和未來需求。此外，報告還重點介紹了所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的綜合概況以及全球競爭格局的深入分析。生物晶片市場的主要參與者包括雅培實驗室、安捷倫科技公司、珀金埃爾默公司、Fluidigm公司、Illumina公司、通用電氣醫療保健公司、Bio-Rad實驗室公司、賽默飛世爾科技公司、LI-COR公司、分子設備有限責任公司。本節包括競爭格局的整體視圖，其中包括各種戰略發展，如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

目 錄

第一章：前言

  • 報告描述
    • 報告目標
    • 目標受眾
    • 獨特銷售主張（USP）和產品
  • 研究範圍
  • 研究方法
    • 市場調研流程
    • 市場調研方法

第二章：執行摘要

  • 市場亮點
  • 全球市場概況

第三章：生物晶片-行業分析

  • 簡介- 市場動態
  • 市場驅動因素
  • 市場限制因素
  • 市場機會
  • 行業趨勢
  • 波特五力分析
  • 市場吸引力分析
    • 按類型分類的市場吸引力分析
    • 按最終用途的市場吸引力分析
    • 市場吸引力分析：按地區

第四章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料製造商列表
    • 主要原料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直接行銷
    • 間接行銷
    • 行銷管道發展趨勢

第五章：全球生物晶片市場分析：按類型分類

  • 類型概述
  • 歷史和預測數據
  • 按類型分析
  • DNA晶片（癌症診斷和治療、基因表達、SNP基因分型、基因組學、藥物發現、農業生物技術、其他）
  • 蛋白質晶片（蛋白質組學、表達譜分析、診斷、HTS、藥物發現、其他）
  • 晶片實驗室（基因組學、IVD和POC、蛋白質組學、藥物研發、其他）
  • 組織晶片
  • 細胞晶片

第六章：全球生物晶片市場分析：按最終用途分類

  • 終端用途概述
  • 歷史和預測數據
  • 按最終用途分析
  • 生物技術和製藥公司
  • 醫院和診斷中心
  • 學術研究機構
  • 其他

第七章：全球生物晶片市場分析：按地域分類

  • 地區前景
  • 地區介紹
  • 北美銷售分析
    • 概述、歷史和預測數據銷售分析
    • 北美細分市場銷售分析
    • 北美各國銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 歐洲銷售分析
    • 歐洲各國銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測數據銷售分析
    • 亞太地區細分市場銷售分析
    • 亞太地區各國銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳大利亞銷售分析
    • 亞太其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 拉丁美洲各細分市場銷售分析
    • 拉丁美洲各國銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 中東及非洲地區銷售分析
    • 中東及非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東和非洲其他地區銷售分析

第八章: 生物晶片企業競爭格局

  • 生物晶片市場競爭
  • 夥伴關係/合作/協議
  • 合併與收購
  • 新產品發布
  • 其他發展

第九章: 公司概況

  • 頂級公司市場佔有率分析
  • 市場集中度
  • Abbott Laboratories
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Agilent Technologies Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • PerkinElmer Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Fluidigm Corp.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Illumina Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • GE Healthcare
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Bio-Rad Laboratories Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Thermo Fisher Scientific Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • LI-COR Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Molecular Devices LLC
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展

注-在公司概況中，財務細節和近期發展視情況而定，如果是私營公司則可能不包括在內。

Product Code: VMR112111184

The global demand for Biochips Market is presumed to reach the market size of nearly USD 27.19 BN by 2030 from USD 8.91 BN in 2022 with a CAGR of 14.97% under the study period 2023 - 2030.

Biochips, also known as microarrays, are small devices made up of tiny microchips or glass slides that are used to study biological molecules such as DNA, RNA, and proteins. These devices have thousands to millions of microscopic spots, each containing a different biological molecule. These work by binding the biological molecules of interest to the spots on the chip's surface, which can then be analyzed using various methods, such as fluorescence, chemiluminescence, or mass spectrometry. By analyzing the signals from each spot on the chip, researchers can obtain a wealth of information about the biological samples being analyzed.

Market Dynamics:

The growing trend towards personalized medicine, which involves tailoring medical treatment to an individual's genetic makeup, is driving the demand for biochips. These are used to analyze DNA, RNA, and protein samples, which can provide valuable information for developing personalized treatment plans. Advancements in genomics and proteomics research, such as the development of next-generation sequencing and mass spectrometry technologies, are also adding to the demand curve of this market. These are used in technologies to analyze large amounts of biological data quickly and efficiently. The adoption of microarray technology is increasing rapidly in research, diagnostics, and drug development. Biochips are a key component of microarray technology, which is used to study gene expression and protein interactions. The increasing incidence of chronic diseases, including cancer, cardiovascular diseases, and diabetes, is also supporting this market. Biochips are used in the diagnosis, treatment, and monitoring of these diseases, which are becoming more prevalent due to factors such as ageing populations and unhealthy lifestyles. Technological advancements, such as the development of lab-on-a-chip and microfluidics technologies, are also assisting the growth of this market. These technologies allow for faster and more accurate analysis of biological samples, which is critical in research and diagnostics. Heavy investments from various Governments are also supporting this market. For example, the US government has launched several initiatives aimed at advancing genomics research and personalized medicine, which is expected to boost the demand.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of biochips. The growth and trends of biochips industry provide a holistic approach to this study.

Market Segmentation:

This section of the biochips market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • DNA Chips (Cancer Diagnosis And Treatment, Gene Expression, SNP Genotyping, Genomics, Drug Discovery, Agricultural Biotechnology, Others)
  • Protein Chips (Proteomics, Expression Profiling, Diagnostics, HTS, Drug Discovery, Others)
  • Lab-On-Chip (Genomics, IVD & POC, Proteomics, Drug Discovery, Others)
  • Tissue Arrays
  • Cell Arrays

By End-Use

  • Biotechnology And Pharmaceutical Companie
  • Hospitals And Diagnostics Centers
  • Academic & Research Institutes
  • Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Biochips market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the biochips market include Abbott Laboratories, Agilent Technologies, Inc., PerkinElmer, Inc., Fluidigm Corp., Illumina, Inc., GE Healthcare, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., LI-COR, Inc., Molecular Devices, LLC. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . BIOCHIPS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By End-use
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL BIOCHIPS MARKET ANALYSIS BY TYPE

  • 5.1 Overview by Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Type
  • 5.4 DNA Chips (Cancer Diagnosis And Treatment, Gene Expression, SNP Genotyping, Genomics, Drug Discovery, Agricultural Biotechnology, Others) Historic and Forecast Sales by Regions
  • 5.5 Protein Chips (Proteomics, Expression Profiling, Diagnostics, HTS, Drug Discovery, Others) Historic and Forecast Sales by Regions
  • 5.6 Lab-on-chip (Genomics, IVD & POC, Proteomics, Drug Discovery, Others) Historic and Forecast Sales by Regions
  • 5.7 Tissue Arrays Historic and Forecast Sales by Regions
  • 5.8 Cell Arrays Historic and Forecast Sales by Regions

6 . GLOBAL BIOCHIPS MARKET ANALYSIS BY END-USE

  • 6.1 Overview by End-use
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by End-use
  • 6.4 Biotechnology And Pharmaceutical Companie Historic and Forecast Sales by Regions
  • 6.5 Hospitals And Diagnostics Centers Historic and Forecast Sales by Regions
  • 6.6 Academic & Research Institutes Historic and Forecast Sales by Regions
  • 6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL BIOCHIPS MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2. North America By Segment Sales Analysis
    • 7.3.3. North America By Country Sales Analysis
    • 7.3.4. United State Sales Analysis
    • 7.3.5. Canada Sales Analysis
    • 7.3.6. Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2. Europe by Segment Sales Analysis
    • 7.4.3. Europe by Country Sales Analysis
    • 7.4.4. United Kingdom Sales Analysis
    • 7.4.5. France Sales Analysis
    • 7.4.6. Germany Sales Analysis
    • 7.4.7. Italy Sales Analysis
    • 7.4.8. Russia Sales Analysis
    • 7.4.9. Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2. Asia Pacific by Segment Sales Analysis
    • 7.5.3. Asia Pacific by Country Sales Analysis
    • 7.5.4. China Sales Analysis
    • 7.5.5. India Sales Analysis
    • 7.5.6. Japan Sales Analysis
    • 7.5.7. South Korea Sales Analysis
    • 7.5.8. Australia Sales Analysis
    • 7.5.9. Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2. Latin America by Segment Sales Analysis
    • 7.6.3. Latin America by Country Sales Analysis
    • 7.6.4. Brazil Sales Analysis
    • 7.6.5. Argentina Sales Analysis
    • 7.6.6. Peru Sales Analysis
    • 7.6.7. Chile Sales Analysis
    • 7.6.8. Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2. Middle East & Africa by Segment Sales Analysis
    • 7.7.3. Middle East & Africa by Country Sales Analysis
    • 7.7.4. Saudi Arabia Sales Analysis
    • 7.7.5. UAE Sales Analysis
    • 7.7.6. Israel Sales Analysis
    • 7.7.7. South Africa Sales Analysis
    • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE BIOCHIPS COMPANIES

  • 8.1. Biochips Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF BIOCHIPS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Abbott Laboratories
    • 9.3.1. Company Overview
    • 9.3.2. Company Revenue
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. Agilent Technologies Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Company Revenue
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. PerkinElmer Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Company Revenue
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. Fluidigm Corp.
    • 9.6.1. Company Overview
    • 9.6.2. Company Revenue
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Illumina Inc.
    • 9.7.1. Company Overview
    • 9.7.2. Company Revenue
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. GE Healthcare
    • 9.8.1. Company Overview
    • 9.8.2. Company Revenue
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. Bio-Rad Laboratories Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Company Revenue
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Thermo Fisher Scientific Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Company Revenue
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. LI-COR Inc.
    • 9.11.1. Company Overview
    • 9.11.2. Company Revenue
    • 9.11.3. Products
    • 9.11.4. Recent Developments
  • 9.12. Molecular Devices LLC
    • 9.12.1. Company Overview
    • 9.12.2. Company Revenue
    • 9.12.3. Products
    • 9.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Type (USD MN)
  • DNA Chips (Cancer Diagnosis And Treatment, Gene Expression, SNP Genotyping, Genomics, Drug Discovery, Agricultural Biotechnology, Others) Market Sales by Geography (USD MN)
  • Protein Chips (Proteomics, Expression Profiling, Diagnostics, HTS, Drug Discovery, Others) Market Sales by Geography (USD MN)
  • Lab-on-chip (Genomics, IVD & POC, Proteomics, Drug Discovery, Others) Market Sales by Geography (USD MN)
  • Tissue Arrays Market Sales by Geography (USD MN)
  • Cell Arrays Market Sales by Geography (USD MN)
  • Analysis Market by End-use (USD MN)
  • Biotechnology And Pharmaceutical Companie Market Sales by Geography (USD MN)
  • Hospitals And Diagnostics Centers Market Sales by Geography (USD MN)
  • Academic & Research Institutes Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Biochips Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Biochips Report
  • Market Research Process
  • Market Research Methodology
  • Global Biochips Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by End-use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • DNA Chips (Cancer Diagnosis And Treatment, Gene Expression, SNP Genotyping, Genomics, Drug Discovery, Agricultural Biotechnology, Others) Market Sales by Geography (USD MN)
  • Protein Chips (Proteomics, Expression Profiling, Diagnostics, HTS, Drug Discovery, Others) Market Sales by Geography (USD MN)
  • Lab-on-chip (Genomics, IVD & POC, Proteomics, Drug Discovery, Others) Market Sales by Geography (USD MN)
  • Tissue Arrays Market Sales by Geography (USD MN)
  • Cell Arrays Market Sales by Geography (USD MN)
  • Global Market Analysis by End-use (USD MN)
  • Biotechnology And Pharmaceutical Companie Market Sales by Geography (USD MN)
  • Hospitals And Diagnostics Centers Market Sales by Geography (USD MN)
  • Academic & Research Institutes Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.